Add BrightSurf on Google Email

Multi-level program enhances primary care treatment for opioid use disorder in rural Colorado

A multilevel program improved the awareness and adoption of buprenorphine treatment for opioid use disorder in rural Colorado. The program increased the proportion of practices providing or referring patients for treatment from 18.8% to 74.4%, with a significant increase in buprenorphine prescriptions over four years.

SourceAmerican Academy of Family Physicians·JournalThe Annals of Family Medicine·DateJan 26, 2022

Addressing substance use and pain key to limiting self-directed hospital discharge

A new study from the University of Pennsylvania School of Nursing found that patients with acute painful admitting diagnoses were almost twice as likely to have a self-directed discharge than those without. Inadequate pain assessment may be a motivator for this behavior, leading to poorer health outcomes and preventable financial costs.

SourceUniversity of Pennsylvania School of Nursing·JournalHarm Reduction Journal·DateJan 19, 2022

Drug combination reduces narcotic use, manages pain after surgery for teens with scoliosis

A new study suggests that combining two drugs can reduce postoperative opioid use and side effects in adolescents with scoliosis. The combination of intrathecal morphine and oral gabapentin provides more effective pain control, resulting in fewer side effects and lower narcotic consumption.

SourceMichigan Medicine - University of Michigan·JournalJournal of Orthopaedic Surgery and Research·TypeData/statistical analysis·DateJan 4, 2022

New study highlights key health opportunities, causes of death for Coloradans

A Colorado State University study analyzed global health data to identify the leading causes of deaths and disabilities in the state from 1990 to 2019. Cardiovascular disease and cancers accounted for half of the deaths, while musculoskeletal disorders and tobacco use were also significant contributors.

SourceColorado State University·JournalInternational Journal of Environmental Research and Public Health·TypeData/statistical analysis·DateJan 3, 2022

Opioid prescribing declines, but cuts are not uniform

Per capita morphine milligram equivalents (MME) volume declined most in metropolitan counties and counties with higher fatal opioid overdoses. Clinical specialties showed significant declines, except for some states' counties with both increases and decreases.

SourceRAND Corporation·JournalAnnals of Internal Medicine·TypeData/statistical analysis·DateDec 27, 2021

Improving medication treatment leads to dramatic gains in emergency department care for opioid use disorder

A program at the University of Pennsylvania School of Medicine increased buprenorphine treatment rates in emergency departments by sixfold, from 3% to 23%, and sustained the changes. The program used behavioral design tactics and automated connections to peer recovery specialists to overcome barriers to treatment.

SourceUniversity of Pennsylvania School of Medicine·JournalAnnals of Emergency Medicine·TypeExperimental study·DateDec 23, 2021

Change in buprenorphine use in US jails, prisons

The study found that buprenorphine use for opioid use disorder increased substantially in US jails and prisons over the past five years. Despite being rare among incarcerated individuals with opioid use disorder, this increase suggests potential improvements in treatment access.

SourceJAMA Network·JournalJAMA Network Open·DateDec 14, 2021

Childhood trauma increases risk of opioid abuse

A new study found that childhood trauma is a significant risk factor for prescription opioid misuse among young adults. Participants who reported four or more adverse childhood experiences were nearly three times more likely to be at risk for opioid misuse, with a 13% higher likelihood compared to those with zero to three ACEs.

SourceUniversity of Georgia·JournalJournal of American College Health·DateDec 9, 2021

LSU Health New Orleans study finds dramatic drop in opioid rx after state legislation enacted

A LSU Health New Orleans study reports a nearly 70% decrease in morphine milligram equivalent (MME) per discharge opioid prescriptions for patients who underwent common lower extremity surgical procedures. The study also found a significant decline in new opioid prescriptions, from 50% in 2013 to 19.3% in 2018.

SourceLouisiana State University Health Sciences Center·JournalJournal of the American Academy of Orthopaedic Surgeons·TypeSystematic review·DateDec 7, 2021

New study identifies gaps in treatment for opioid use disorder as overdose emergencies soar

A new study found that emergency physicians are missing opportunities to prescribe life-saving medications like naloxone and buprenorphine after opioid overdose visits. The study analyzed over 149,000 visits between 2019-2021 and discovered that naloxone was prescribed only in 7.4% of cases, while buprenorphine was prescribed in only 8...

SourceAmerican College of Emergency Physicians·JournalAnnals of Emergency Medicine·DateNov 30, 2021

About 12 percent of patients who receive common cardiac device implants develop persistent opioid use

A new study by researchers at the University of Pennsylvania School of Medicine found that 12.4% of patients who received implantable cardiac devices and filled an opioid prescription within two weeks of surgery developed persistent opioid use. Higher initial prescriptions were associated with a higher risk of persistent opioid use.

SourceUniversity of Pennsylvania School of Medicine·JournalCirculation·TypeData/statistical analysis·DateNov 26, 2021

Less than 10% of opioid overdose patients are prescribed potentially lifesaving medications after emergency treatment

A Michigan Medicine study found that only 7.4% of patients received naloxone and 8.5% received buprenorphine prescriptions within 30 days of an opioid overdose. The low rates highlight missed opportunities for equipping patients with rescue medicines to use in case of future overdoses.

SourceMichigan Medicine - University of Michigan·JournalAnnals of Emergency Medicine·TypeData/statistical analysis·DateNov 23, 2021

Using short-acting opioids in the hospital could improve care for patients experiencing opioid withdrawal without pain

Experts suggest expanding treatment options for hospital patients with opioid withdrawal symptoms, potentially allowing more individualized and patient-centered care. Randomized controlled trials are needed to determine the efficacy of short-acting opioids in this context.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeCommentary/editorial·DateNov 22, 2021

Henry ford study shows non-opioids provide effective pain relief after knee surgery

A Henry Ford Health System study published in The American Journal of Sports Medicine found that a novel opioid-free pain management protocol provided the same pain relief for patients as common types of prescription opioids. This approach aims to reduce opioid misuse and promote more effective pain management after ACL knee reconstruc...

SourceHenry Ford Health·JournalThe American Journal of Sports Medicine·TypeRandomized controlled/clinical trial·DateNov 17, 2021

OHSU model reduces opioid prescribing

A review board comprising healthcare professionals from various disciplines has sharply reduced opioid prescribing at an OHSU internal medicine clinic. The clinic uses a systematic approach to review high-risk cases and coach primary care providers on tapering patients off opioids.

SourceOregon Health & Science University·JournalThe Annals of Family Medicine·TypeData/statistical analysis·DateNov 9, 2021

CBT intervention with yoga and education components improved pain management for patients on long-term opioids better than usual care

A randomized controlled trial found that CBT with yoga and education components significantly reduced pain impact and disability in patients on long-term opioid therapy. Patients receiving CBT also reported greater reductions in pain compared to those receiving usual care.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeRandomized controlled/clinical trial·DateNov 1, 2021

Survey of US dentists shows high rate of opioid prescriptions despite knowledge of effective alternatives

A survey of US dentists found that an overwhelming majority believe nonsteroidal anti-inflammatory drug (NSAID)-acetaminophen combinations are as effective or more effective in managing dental pain as opioids. However, nearly half still prescribe opioids, highlighting a disconnect between their knowledge and prescribing habits.

SourceGeorgetown University Medical Center·JournalThe Journal of the American Dental Association·TypeSurvey·DateOct 21, 2021

Overdose deaths involving cocaine or meth tripled in shadow of opioid crisis

Overdose deaths involving cocaine or methamphetamine increased triply in the shadow of the opioid epidemic. Most fatal overdoses (70%) involved multiple substances, with most being opioids and stimulants. The study highlights disparities in overdose risk from stimulants among Black veterans and rural residents.

SourceMichigan Medicine - University of Michigan·JournalAddiction·TypeData/statistical analysis·DateOct 20, 2021

Buprenorphine misuse decreased among U.S. adults with opioid use disorder from 2015-2019

A study published in JAMA Network Open found that nearly three-fourths of U.S. adults with buprenorphine use did not misuse the medication in 2019, trending downward between 2015-2019 despite increased treatment. The research highlights the need to expand access to proven treatment approaches like buprenorphine therapy to reduce misuse.

SourceNIH/National Institute on Drug Abuse·JournalJAMA Network Open·DateOct 15, 2021

With new NIH Small Business Innovation Research Award, scientists at Lewis Katz School of Medicine at Temple University set to test novel cannabis analog in preclinical studies

Scientists at Temple University will explore the therapeutic potential of KLS-13019, a CBD analog that shows promise as an opioid alternative. The Phase 2 SBIR grant aims to test the compound's effects on rat models of neuropathic pain, shedding light on its safety and efficacy.

Racial, ethnic differences in opioid prescribing

A study analyzing Medicare data found that racial and ethnic minority groups received fewer opioid prescriptions for new low back pain compared to white patients. This disparity persisted during the first wave of the opioid epidemic, despite growing awareness of its adverse effects.

SourceJAMA Network·JournalJAMA Health Forum·DateSep 10, 2021

Study identifies the importance of modeling neonatal opioid withdrawal and brain adaptations in both sexes

Researchers identified sex-dependent changes in gene expression in the brainstem during neonatal opioid withdrawal, which could lead to new therapeutic targets for preventing or mitigating Neonatal Opioid Withdrawal Syndrome symptoms. The study found that prenatal opioid exposure compromised neurodevelopmental 'wiring' of the brain and...

SourceBoston University School of Medicine·JournaleNeuro·TypeExperimental study·DateSep 9, 2021

Brain gene expression patterns altered by chronic opioid use

A new study has found that chronic opioid use changes gene expression in the brains of people with opioid use disorder (OUD), suggesting proinflammatory signaling and synaptic remodeling. The affected genes involved in immune response and neuronal connections were also identified, offering new targets for treatment.

SourceElsevier·JournalBiological Psychiatry·TypeComputational simulation/modeling·DateAug 10, 2021